← Eichor
Study identifier: NCT03052283 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Development and Validation of a Disease Specific PROM to Assess Abdominal Involvement in Patients With CF (CFAbd-Score)

Condition: Cystic Fibrosis  ·  Sponsor: Medizinische Hochschule Brandenburg Theodor Fontane

PhaseN/A
Planned participants2000
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersYes

About this study

Development, validation and evaluation of a new multimodal questionnaire to assess and quantify the abdominal involvement in patients with the inherited life shortening multi-organ disease Cystic fibrosis. In the stepwhise development of the patient reported outcome measures (PROM) repeadedly, CF-patients, their families as well as professionals working in different fields of CF-care will be included.

This description comes directly from the study's public registry record.

Talk to the study team

Jochen G Mainz, Prof. MD  ·  +493381411803  ·  jochen.mainz@mhb-fontane.de

Franziska Duckstein, MA  ·  +493381411841  ·  f.duckstein@klinikum-brandenburg.de

Always discuss trial participation with your own doctor first.

Locations (2)

Klinikum WestbrandenburgBrandenburg an der Havel, GermanyRecruiting
Medizinische Hochschule Brandenburg (MHB), UniversityBrandenburg an der Havel, GermanyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03052283